Jpmorgan Chase & CO Kamada LTD Transaction History

Jpmorgan Chase & CO

  • $1.14 Trillion
  • Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Kamada LTD stock. As of the latest transaction made, Jpmorgan Chase & CO holds 151,949 shares of KMDA stock, worth $910,174. This represents 0.0% of its overall portfolio holdings.

Number of Shares
151,949
Previous 122,380 24.16%
Holding current value
$910,174
Previous $686,000 9.77%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$4.78 - $5.75 $141,339 - $170,021
29,569 Added 24.16%
151,949 $753,000
Q1 2024

May 10, 2024
BUY
$5.58 - $6.42 $606,585 - $697,898
108,707 Added 795.05%
122,380 $686,000
Q4 2023

Feb 12, 2024
BUY
$4.14 - $6.22 $56,606 - $85,046
13,673 New
13,673 $83,000
Q2 2023

Aug 11, 2023
BUY
$4.48 - $5.53 $70,900 - $87,517
15,826 New
15,826 $83,000
Q3 2022

Nov 14, 2022
SELL
$4.42 - $5.43 $31,828 - $39,101
-7,201 Reduced 20.01%
28,787 $130,000
Q2 2022

Aug 11, 2022
SELL
$4.22 - $5.85 $54,286 - $75,254
-12,864 Reduced 26.33%
35,988 $162,000
Q1 2022

May 11, 2022
SELL
$5.43 - $6.81 $217,547 - $272,835
-40,064 Reduced 45.06%
48,852 $269,000
Q4 2021

Feb 10, 2022
SELL
$5.21 - $6.82 $121,247 - $158,715
-23,272 Reduced 20.74%
88,916 $585,000
Q3 2021

Nov 12, 2021
BUY
$5.25 - $5.87 $588,987 - $658,543
112,188 New
112,188 $595,000

Others Institutions Holding KMDA

# of Institutions
36
Shares Held
6.39M
Call Options Held
2.2K
Put Options Held
63.8K
View Full List

About KAMADA LTD

KMDA Quotes by TradingView
  • Ticker KMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 44,800,500
  • Market Cap $268M
  • Description
  • Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...
More about KMDA
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email